Association of the BellaGel® Breast Implant Scandal with the Poly Implant Prothèse Fraud: A Review of Literatures

  • JH K
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Marketing defective breast implants (BellaGel®; HansBiomed Co. Ltd., Seoul, Korea) despite knowledge or reasonable cause to believe that the device is defective has been recently found in Korea, thus termed as the BellaGel® breast implant scandal. Evidence suggests that the HansBiomed Co. Ltd. previously participated in the Poly Implant Prothèse (PIP) fraud in Europe. Based on the fact that the manufacturer was previously involved in the PIP fraud, it would be mandatory to consider long-term safety outcomes of victims of the BellaGel® breast implant scandal.

Cite

CITATION STYLE

APA

JH, K. (2021). Association of the BellaGel® Breast Implant Scandal with the Poly Implant Prothèse Fraud: A Review of Literatures. Journal of Surgery: Open Access, 7(1). https://doi.org/10.16966/2470-0991.230

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free